SOGON 46th Annual General Meeting

During this meeting of the Society of Gynaecology and Obstetrics of Nigeria, Gynuity staff and colleagues presented two papers on the use of misoprostol for treatment of incomplete abortion. One paper highlighted a study reporting its use in 5 sub-Saharan African countries: Burkina Faso, Mauritania, Niger, Nigeria and Senegal. The results provide additional evidence for the misoprostol regimen evaluated and demonstrate the feasibility of its use in this context. The second presentation reported on a study evaluating the feasibility of introducing misoprostol as first-line treatment for incomplete abortion at a secondary-level health facility in Nigeria. The results demonstrate that misoprostol can be successfully used as first-line treatment by nurse–midwives, with success rates over 90% that are consistent with findings from previous studies in which drug administration was controlled solely by physicians.